STOCKHOLM, April 4 (Reuters) - Shares in drug maker Meda AB were halted on Friday following a media report that Mylan Inc is looking to acquire its smaller Swedish rival in a move that would create a $23 billion company.
Meda’s chairman confirmed to Swedish news agency Direkt on Friday that the company had had initial contact with Mylan and said it would make an announcement later in the day on Friday.
Help employers find you! Check out all the jobs and post your resume.
